4.2 Article

Missing Data in Alcohol Clinical Trials with Binary Outcomes

Journal

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
Volume 40, Issue 7, Pages 1548-1557

Publisher

WILEY-BLACKWELL
DOI: 10.1111/acer.13106

Keywords

Alcohol Clinical Trials; Missing Data; Multiple Imputation; Simulation Study; Naltrexone

Funding

  1. NIAAA [T32AA007455, R01AA022328]
  2. Abbvie
  3. Alkermes
  4. Ethypharm
  5. Lilly
  6. Lundbeck
  7. Pfizer

Ask authors/readers for more resources

BackgroundMissing data are common in alcohol clinical trials for both continuous and binary end points. Approaches to handle missing data have been explored for continuous outcomes, yet no studies have compared missing data approaches for binary outcomes (e.g., abstinence, no heavy drinking days). This study compares approaches to modeling binary outcomes with missing data in the COMBINE study. MethodsWe included participants in the COMBINE study who had complete drinking data during treatment and who were assigned to active medication or placebo conditions (N=1,146). Using simulation methods, missing data were introduced under common scenarios with varying sample sizes and amounts of missing data. Logistic regression was used to estimate the effect of naltrexone (vs. placebo) in predicting any drinking and any heavy drinking outcomes at the end of treatment using 4 analytic approaches: complete case analysis (CCA), last observation carried forward (LOCF), the worst case scenario (WCS) of missing equals any drinking or heavy drinking, and multiple imputation (MI). In separate analyses, these approaches were compared when drinking data were manually deleted for those participants who discontinued treatment but continued to provide drinking data. ResultsWCS produced the greatest amount of bias in treatment effect estimates. MI usually yielded less biased estimates than WCS and CCA in the simulated data and performed considerably better than LOCF when estimating treatment effects among individuals who discontinued treatment. ConclusionsMissing data can introduce bias in treatment effect estimates in alcohol clinical trials. Researchers should utilize modern missing data methods, including MI, and avoid WCS and CCA when analyzing binary alcohol clinical trial outcomes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Substance Abuse

Cognitive training and remediation interventions for substance use disorders: a Delphi consensus study

Antonio Verdejo-Garcia, Tara Rezapour, Emily Giddens, Arash Khojasteh Zonoozi, Parnian Rafei, Jamie Berry, Alfonso Caracuel, Marc L. Copersino, Matt Field, Eric L. Garland, Valentina Lorenzetti, Leandro Malloy-Diniz, Victoria Manning, Ely M. Marceau, David L. Pennington, Justin C. Strickland, Reinout Wiers, Rahia Fairhead, Alexandra Anderson, Morris Bell, Wouter J. Boendermaker, Samantha Brooks, Raimondo Bruno, Salvatore Campanella, Janna Cousijn, W. Miles Cox, Andrew C. Dean, Karen D. Ersche, Ingmar Franken, Brett Froeliger, Pedro Gamito, Thomas E. Gladwin, Priscila D. Goncalves, Katrijn Houben, Joanna Jacobus, Andrew Jones, Anne M. Kaag, Johannes Lindenmeyer, Elly McGrath, Talia Nardo, Jorge Oliveira, Charlotte R. Pennington, Kelsey Perrykkad, Hugh Piercy, Claudia Rupp, Mieke H. J. Schulte, Lindsay M. Squeglia, Petra Staiger, Dan J. Stein, Jeff Stein, Maria Stein, William W. Stoops, Mary Sweeney, Katie Witkiewitz, Steven P. Woods, Richard Yi, Min Zhao, Hamed Ekhtiari

Summary: This study used a Delphi approach to reach consensus on recommendations for developing and applying cognitive training and remediation interventions for substance use disorders. Through two rounds of surveys, experts reached consensus on the targets, approaches, active ingredients, and modes of delivery for these interventions. The study indicates that intervention measures based on validated techniques and flexible delivery methods can effectively improve cognitive deficits in the treatment of substance use disorders.

ADDICTION (2023)

Article Substance Abuse

An intensive longitudinal examination of topiramate treatment for alcohol use disorder: a secondary analysis of data from a randomized controlled trial

Victoria R. R. Votaw, Katie Witkiewitz, M. Lee Van Horn, Richard C. C. Crist, Timothy Pond, Henry R. R. Kranzler

Summary: This study aimed to investigate whether a single-nucleotide polymorphism (rs2832407) in GRIK1 moderates the effects of topiramate treatment for drinking reduction. The results showed that topiramate treatment was effective in reducing daily heavy drinking and desire to drink, and this effect was not influenced by the rs2832407*C-allele homozygotes.

ADDICTION (2023)

Editorial Material Substance Abuse

Announcing a name change for ACER

Henry R. R. Kranzler

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2023)

Article Psychology, Biological

Precision Medicine in Alcohol Use Disorder: Mapping Etiologic and Maintenance Mechanisms to Mechanisms of Behavior Change to Improve Patient Outcomes

Cassandra L. Boness, Katie Witkiewitz

Summary: This article discusses the overlap between alcohol use disorder treatment and etiologic maintenance mechanisms, suggesting areas for further research and potential improvements in treatment efficacy. By leveraging these overlapping processes, it may be possible to identify treatment targets and enhance the effectiveness of existing treatments.

EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2023)

Article Substance Abuse

Alcohol use disorder conceptualizations and diagnoses reflect their sociopolitical context

Cassandra L. L. Boness, Victoria R. R. Votaw, Meredith W. W. Francis, Ashley L. L. Watts, Sarah H. H. Sperry, Christopher S. S. Kleva, Linda Nellis, Yoanna McDowell, Antoine B. B. Douaihy, Kenneth J. J. Sher, Katie Witkiewitz

Summary: This paper discusses the evolution of conceptualizations and diagnostic criteria for alcohol use disorder (AUD) in the United States, influenced by sociopolitical factors. It provides four examples of how DSM-defined alcoholism, abuse/dependence, and AUD have been influenced by sociopolitical factors. The importance of recognizing and understanding these sociopolitical factors in the application of AUD diagnoses is emphasized. Furthermore, a roadmap is offered to improve the diagnosis of AUD, focusing on falsifiability, acknowledging researchers' assumptions about human behavior, and collaboration across subfields. Such efforts have the potential to minimize sociopolitical influences in the development of diagnostic criteria and maximize the treatment utility of diagnoses.

ADDICTION RESEARCH & THEORY (2023)

Review Substance Abuse

Medications for treating alcohol use disorder: A narrative review

Henry R. Kranzler, Emily E. Hartwell

Summary: Chronic heavy alcohol use has negative impacts on neurotransmitter systems and causes various medical, psychiatric, and social problems. Evidence-based medications for treating alcohol use disorder (AUD) are not widely used in clinical practice. Pharmacogenetic approaches have gained interest but have not yet yielded strong enough results for routine clinical care.

ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH (2023)

Article Substance Abuse

Pilot randomized controlled trial of mindfulness-based relapse prevention vs cognitive behavioral therapy for smoking and alcohol use

Christine Vinci, Steven K. Sutton, Min-Jeong Yang, Sana Baban, Rachel Sauls, Katie Witkiewitz, Karen O. Brandon, Marina Unrod, Thomas H. Brandon, David W. Wetter

Summary: This pilot study evaluated the feasibility and acceptability of a mindfulness-based intervention for addressing both smoking and alcohol use. The results showed that the intervention had comparable outcomes to cognitive behavioral therapy (CBT) in reducing tobacco and alcohol use. Future research should conduct large-scale trials to evaluate the efficacy of this intervention.

DRUG AND ALCOHOL DEPENDENCE (2023)

Article Psychology, Clinical

Treatment retention and reductions in blood alcohol concentration (BAC) during the first 90 days of a telehealth program for alcohol use disorder

Kevin A. Hallgren, Gantt P. Galloway, Katie Witkiewitz, Paul Linde, Bob Nix, John E. Mendelson

Summary: This study investigated the 90-day treatment retention and changes in blood alcohol concentration (BAC) in a large cohort receiving AUD telehealth. The results showed that most patients had good retention rates during the 90-day treatment period, and there was a significant reduction in estimated daily peak BAC. This suggests that telehealth is a viable approach for promoting drinking reductions in AUD treatment.

AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2023)

Article Psychiatry

Multi-trait genome-wide association analyses leveraging alcohol use disorder findings identify novel loci for smoking behaviors in the Million Veteran Program

Youshu Cheng, Cecilia Dao, Hang Zhou, Boyang Li, Rachel L. Kember, Sylvanus Toikumo, Hongyu Zhao, Joel Gelernter, Henry R. Kranzler, Amy C. Justice, Ke Xu

Summary: Smoking behaviors and alcohol use disorder commonly co-occur and are moderately heritable. Previous single-trait GWAS studies have identified multiple loci for smoking and AUD. However, limited by small samples, GWASs aiming to identify loci contributing to co-occurring smoking and AUD have been less informative. Using multi-trait analysis of GWASs (MTAG) with data from the Million Veteran Program, this study identified novel loci associated with smoking initiation and cessation. Functional annotation highlighted biologically important regions contributing to smoking behaviors. MTAG results did not enhance discovery for smoking behaviors and alcohol consumption compared to single-trait GWAS. This study provides new insights into the pleiotropic effects of genetic variants on smoking behavior and AUD through the application of MTAG.

TRANSLATIONAL PSYCHIATRY (2023)

Article Psychology, Multidisciplinary

Everybody Hurts: Intersecting and Colliding Epidemics and the Need for Integrated Behavioral Treatment of Chronic Pain and Substance Use

Katie Witkiewitz, Kevin E. Vowles

Summary: Chronic pain and substance use disorders (SUDs) are prevalent and persisting issues, with a significant proportion of the adult population being affected by them. Accessing evidence-based treatments for both conditions is challenging, but ongoing research is shedding light on the mechanisms and co-occurrence of chronic pain and substance use. Integrated behavioral treatments based on acceptance and mindfulness are being developed and tested, and there are increasing efforts in research funding, training, dissemination, and implementation of evidence-based treatments.

CURRENT DIRECTIONS IN PSYCHOLOGICAL SCIENCE (2023)

Review Substance Abuse

Effects of Cognitive Behavioral Techniques for Gambling on Recovery Defined by Gambling, Psychological Functioning, and Quality of Life: A Systematic Review and Meta-Analysis

Rory A. Pfund, Shelby A. King, David P. Forman, James M. Zech, Meredith K. Ginley, Samuel C. Peter, Nicholas W. McAfee, Katie Witkiewitz, James P. Whelan

Summary: The objective of this study was to examine the effect of cognitive behavioral techniques on gambling-related harms, psychological symptoms, and quality of life. The results showed that cognitive behavioral techniques significantly reduced anxiety and depression symptoms, and improved the quality of life. However, further research is needed to explore the relationships between gambling harms, psychological symptoms, and quality of life.

PSYCHOLOGY OF ADDICTIVE BEHAVIORS (2023)

Review Psychology, Clinical

An Evaluation of Cognitive Behavioral Therapy for Substance Use Disorders: A Systematic Review and Application of the Society of Clinical Psychology Criteria for Empirically Supported Treatments

Cassandra L. L. Boness, Victoria R. R. Votaw, Frank J. J. Schwebel, David I. K. Moniz-Lewis, R. Kathryn McHugh, Katie Witkiewitz

Summary: Cognitive behavioral therapy (CBT) is an effective treatment for substance use disorders (SUDs), particularly during the early follow-up period.

CLINICAL PSYCHOLOGY-SCIENCE AND PRACTICE (2023)

Article Psychology, Clinical

Prevalence and correlates of DSM-5 opioid withdrawal syndrome in US adults with non-medical use of prescription opioids: results from a national sample

Zachary L. Mannes, Ofir Livne, Justin Knox, Deborah S. Hasin, Henry R. Kranzler

Summary: This study aims to examine the prevalence and clinical correlates of opioid withdrawal syndrome (OWS) among adults in the U.S. who engage in non-medical use of prescription opioids (NMOU). Results revealed that OWS is prevalent among individuals with NMOU and is associated with psychiatric disorders and opioid use disorder (OUD).

AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2023)

Article Substance Abuse

Patterns of drinking behavior around a treatment episode for alcohol use disorder: Predictions from pre-treatment measures

Katie Witkiewitz, Megan Kirouac, James W. Baurley, Christopher S. McMahan

Summary: This study analyzed data from the Project MATCH and COMBINE studies to explore baseline predictors of drinking patterns. The findings suggest that prior drinking patterns are the most consistent predictors of future drinking patterns. Social network drinking, AUD severity, mental health symptoms, and constructs based on the addiction cycle were associated with patterns of drinking prior to treatment. Addiction cycle constructs, AUD severity, purpose in life, social network, legal history, craving, and motivation were associated with drinking during and following treatment.

ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH (2023)

No Data Available